
CATO SMS and Pharm-Olam Merge
Research Triangle Park, N.C.-based
Although smaller businesses currently account for nearly 70% of the biopharmaceutical industry’s intellectual property, they have often found it challenging to receive the full attention of senior resources required to effectively design and manage clinical studies. CATO SMS and Pharm-Olam are joining forces to address this gap and serve the specific needs of small and mid-sized businesses.
Read more about the merge
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.